Plymouth Buys iSOFT Business Intelligence to Raise Labs Performance

iSOFTiSOFT, a CSC company, has agreed a deal with Plymouth Hospitals NHS Trust for a business intelligence tool to boost performance across its busy laboratory departments to deliver continuous service improvements.

Drawing information from the iSOFT laboratory system at Plymouth, the new solution will provide a dashboard to monitor key performance indicators in real time. This includes the turnaround times of test samples to guarantee targets are met. The trust faces local and national NHS targets for A&E specimens for instance, plus contractual targets for commercial treatment centres and private healthcare firms.

"The iSOFT solution will allow us to proactively manage specimens to identify potential breaches in turnaround times before they become critical," said Adrian Heathcote, the trust's pathology IT manager. "This represents a fundamental shift in ethos.

"It is impossible to monitor targets in real time using the data extract tools commonly found in pathology departments, so breaches only become apparent after the event," he added. "The solution will help mitigate risk and is an additional tool to help us continue with our other customer-focused service improvements."

A second phase will see iSOFT's laboratory business intelligence solution used to optimise workflows and improve performance. This includes plans to examine demand to ensure the right people and skills are in place at peak times and to pinpoint bottlenecks.

The solution will used across all three laboratories at Plymouth's Derriford Hospital and across all laboratory disciplines, including histopathology, microbiology, haematology, and clinical biochemistry. The trust's Pathology Directorate employs 257 staff and conducts 6.5 million tests on 1.3 million specimens a year.

"Seventy to eighty percent of diagnoses now rely on pathology tests and the pressure on laboratory services will only intensify," said Adrian Stevens, managing director of iSOFT's UK business. "Our solution gives pathology departments the means to remove inefficiencies and find savings.

"As an early adopter, we will work closely with Plymouth to further shape the product to meet specific NHS needs."

Related news articles:

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 97,000 employees and reported revenue of $16.2 billion for the 12 months ended September 30, 2011.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...